- £256.86m
- £243.64m
- £82.02m
- 100
- 12
- 80
- 72
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 43.3 | 47.1 | 49.8 | 63.4 | 82 |
Cost of Revenue | |||||
Gross Profit | 25.8 | 30.4 | 34.7 | 38.1 | 50 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 36.6 | 42.7 | 44.7 | 60.1 | 74.8 |
Operating Profit | 6.7 | 4.42 | 5.16 | 3.25 | 7.25 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.56 | 4.11 | 4.63 | 2.56 | 7.14 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.07 | 2.88 | 2.36 | 1.5 | 6.81 |
Net Income Before Extraordinary Items | |||||
Net Income | 5.07 | 2.88 | 2.36 | 1.5 | 6.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 5.07 | 2.88 | 2.36 | 1.5 | 6.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.162 | 0.155 | 0.076 | 0.019 | 0.226 |
Dividends per Share |